not available reply to Singh A, Geller HI, Falk RH. Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis. J Am Coll Cardiol. 2017 Feb 14;69(6):757-758
Maurer, M.S., Mundayat, R., Rapezzi, C. (2017). Reply: Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(6), 758-759 [10.1016/j.jacc.2016.11.047].
Reply: Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis
RAPEZZI, CLAUDIO
2017
Abstract
not available reply to Singh A, Geller HI, Falk RH. Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis. J Am Coll Cardiol. 2017 Feb 14;69(6):757-758File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


